Search Login Register

Gerstmann Syndrome (Gerstmann's Syndrome) Summary

Description: A disorder of cognition characterized by the tetrad of finger agnosia, dysgraphia, dyscalculia, and right-left disorientation. The syndrome may be developmental or acquired. Acquired Gerstmann syndrome is associated with lesions in the dominant (usually left) PARIETAL LOBE which involve the angular gyrus or subjacent white matter. (From Adams et al., Principles of Neurology, 6th ed, p457)

Also Known As: Gerstmann's Syndrome; Syndrome, Gerstmann; Acquired Gerstmann Syndrome; Acquired Gerstmann's Syndrome; Developmental Gerstmann's Syndrome Show All >>

Networked: 14 relevant articles (1 outcomes, 1 trials/studies) for this Disease

Key Drugs and Agents for Gerstmann Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antidepressive Agents (Antidepressants) : 1 outcome in 1 result : IBA
  2. A-factor (Streptomyces) : 1 study in 1 result : IBA
  3. Carbon Monoxide : 4 results : IBA
  4. Acetazolamide (Diamox) : 1 result : FDA 13 Generic
  5. glucuronyl glucosamine glycan sulfate (Vessel) : 1 result : IBA
  6. A 17 (A-17) : 1 result : IBA

Diseases Related to Gerstmann Syndrome

  1. Paresis (Hemiparesis)
  2. Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
  3. Wounds and Injuries (Trauma)
  4. Thymoma (Thymic Carcinoma)
  5. Cerebral Hemorrhage
Show All >>

Key Therapies for Gerstmann Syndrome

Efficacy Chart >>
  1. Highly Active Antiretroviral Therapy (HAART) : 1 result
  2. Thrombolytic Therapy : 1 result
  3. Thoracotomy : 1 result
  4. Surgical Portasystemic Shunt (Portosystemic Shunt) : 1 result
  5. Play Therapy (Therapy, Play) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.